Cautious welcome for new glaucoma guidelines

Article

New guidelines, designed to improve the management and diagnosis of chronic open angle glaucoma (COAG) and ocular hypertension have received a cautious commendation from the ophthalmic community.

New guidelines, designed to improve the management and diagnosis of chronic open angle glaucoma (COAG) and ocular hypertension have received a cautious commendation from the ophthalmic community. However, there are concerns about implementation.

“While the guidelines provide much-needed clarity on the diagnosis and management of glaucoma, implementation of the guidance will mean hundreds of thousands of additional hospital visits, most of which will be unnecessary. Optometrists are well- placed to provide a solution to this problem, with appropriate training,” reported Geoff Robertson, AOP professional advisor.

The guidelines, issued by NICE contain a key recommendation that patients should be formally diagnosed by a healthcare professional with a specialist qualification using techniques which few optometrists currently perform (applanation tonometry, gonioscopy and pachymetry). In order to comply with the new guidelines, optometrists will have to refer these patients to a specialist for a formal diagnosis and monitoring. This would normally mean the patient would need to be referred to hospital rather than being seen in the community.

According to The Association of British Dispensing Opticians, The Association of Ophthalmologists, The Association of Optometrists, The College of Optometrists, The Federation of Ophthalmic and Dispensing Opticians and The General Optical Council this would represent an increase of 10% over the 5 million ophthalmic outpatients episodes provided in 2007-8. The General optical Council said the Hospital Eye Service is a highly specialised part of the eye care sector but it will struggle to cope with such a large increase with inevitable consequences for waiting lists and appointment intervals. It may that under the Any Willing Provider programme ophthalmologists working in the community would be able to take on some of any extra workload but this will probably not solve the problem.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
© 2025 MJH Life Sciences

All rights reserved.